Buprenorphine adoption in the National Drug Abuse Treatment Clinical Trials Network
- 31 October 2009
- journal article
- research article
- Published by Elsevier BV in Journal of Substance Abuse Treatment
- Vol. 37 (3), 307-312
- https://doi.org/10.1016/j.jsat.2008.12.004
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Opioid treatment programs in the Clinical Trials Network: Representativeness and buprenorphine adoptionJournal of Substance Abuse Treatment, 2009
- State policy influence on the early diffusion of buprenorphine in community treatment programsSubstance Abuse Treatment, Prevention, and Policy, 2008
- Innovation adoption in substance abuse treatment: Exposure, trialability, and the Clinical Trials NetworkJournal of Substance Abuse Treatment, 2007
- Characteristics of U.S. substance abuse treatment facilities adopting buprenorphine in its initial stage of availabilityDrug and Alcohol Dependence, 2006
- Early adoption of buprenorphine in substance abuse treatment centers: Data from the private and public sectorsJournal of Substance Abuse Treatment, 2006
- The Relationship of Membership in Research Networks to Compliance With Treatment Guidelines for Early-Stage Breast CancerMedical Care, 2005
- Bringing Buprenorphine‐Naloxone Detoxification to Community Treatment Providers: The NIDA Clinical Trials Network Field ExperienceThe American Journal on Addictions, 2004
- Comparison of Logistic Regression versus Propensity Score When the Number of Events Is Low and There Are Multiple ConfoundersAmerican Journal of Epidemiology, 2003
- Putting drug abuse research to use in real-life settingsJournal of Substance Abuse Treatment, 2002
- The Diffusion of Medical InnovationsPublished by Springer Science and Business Media LLC ,1988